| Literature DB >> 36237887 |
Hiroyuki Koshimizu1, Hiroaki Nakashima1, Kei Ando1, Kazuyoshi Kobayashi1, Yusuke Nishimura2, Masaaki Machino1, Sadayuki Ito1, Shunsuke Kanbara1, Taro Inoue1, Hidetoshi Yamaguchi1, Naoki Segi1, Hiroyuki Tomita1, Shiro Imagama1.
Abstract
The diagnosis of pediatric spinal cord tumor is frequently delayed due to the presence of non-specific symptoms. We investigated the factors influencing the delay between the first symptom presentation and the diagnosis for pediatric spinal cord tumor. We retrospectively analyzed 31 patients of age <20 years (18 men, 13 women) who underwent surgery for spinal cord tumor at a single center during 1998-2018. We extracted the relevant data on patients' symptoms, affected spinal location (cervical: C1-7, thoracic: T1-T12, and lumbosacral: L1-S), and tumor anatomical location (extradural, intradural extramedullary, and intramedullary tumor) that could potentially affect the duration of symptom presentation prior to the diagnosis. The most common symptom presented in the patients was pain (n = 22, 71.0 %). Motor symptoms such as paralysis was associated with early diagnosis (P = 0.039). The duration of symptoms prior to diagnosis was found to be significantly longer in patients with spinal tumor in the lumbar-sacral region than in those with the involvement of the cervical and thoracic regions (2.1 ± 1.7 months vs 13.6 ± 12.1 months; P = 0.006 and 2.9 ± 2.2 months vs 13.6 ± 12.1 months; P = 0.012, respectively). Our study results demonstrated that pain was the most common symptom in the examined patients, although it did not affect the delay in diagnosis, whereas the presentation of motor symptoms was helpful in the diagnosis of pediatric spinal cord tumor and the diagnosis could be delayed in lumbar-sacral spinal tumors.Entities:
Keywords: diagnostic delay; pediatrics spinal cord tumor; tumor characteristics
Mesh:
Year: 2022 PMID: 36237887 PMCID: PMC9529625 DOI: 10.18999/nagjms.84.3.516
Source DB: PubMed Journal: Nagoya J Med Sci ISSN: 0027-7622 Impact factor: 0.794
Demographic data for children (N=31)
| Value | |
| Male/Female | 18/13 |
| Age at Surgery (yrs) | 12.5±4.8 |
| Follow-up periods (months) | 73.2±58.6 |
| Symptom-diagnosis interval months (months) | 6.2 ± 8.6 |
| Cervical | 9 (29.0%) |
| Thoracic | 9 (29.0%) |
| Lumbar-Sacral | 10 (32.3%) |
| Extradural | 11 (35.5%) |
| Intradural extramedullary | 11 (35.5%) |
| Intramedullary | 9 (29.0%) |
| Back pain | 14 (45.2%) |
| Neck pain | 2 (6.5%) |
| Extremity pain | 10 (32.3%) |
| Motor symptom | 17 (54.8%) |
| Sensory symptom | 13 (41.9%) |
| Urinary retention | 11 (35.5%) |
Summary characteristic of all patients (N=31)
| Age at
| Sex | Tumor
| Pathology | Pain | Back
| Neck
| Extremity
| Motor
| Sensory
| Urinary
|
| 2 | F | T2T5 | LGG | + | - | - | + | + | + | - |
| 2 | M | L2L5 | Neuroblastoma | + | - | - | + | - | - | - |
| 4 | F | L3S1 | Epithelioid tumor | + | - | - | + | - | - | - |
| 4 | F | C3C4 | Arachnoid cyst | - | - | - | - | + | - | + |
| 6 | F | T8S1 | MPE | + | - | - | + | + | - | + |
| 8 | M | L3S1 | MPE | + | - | - | + | + | - | + |
| 10 | F | T11L2 | Lymphoma | - | - | - | - | + | - | + |
| 10 | F | C7T1 | Cavernous angioma | + | + | - | - | + | + | + |
| 11 | M | C7 | Osteoid osteoma | - | - | - | - | + | - | - |
| 12 | F | L5 | Osteoblastoma | - | - | - | - | - | - | - |
| 12 | M | C2T4 | Ependymoma | - | - | - | - | + | + | + |
| 13 | M | T5T7 | LGG | + | + | - | - | + | + | + |
| 13 | M | C2 | Osteoid osteoma | + | + | + | - | - | - | - |
| 13 | M | T11T12 | Neurofibroma | + | + | - | - | + | + | - |
| 13 | M | C5C6 | Neurofibroma | - | - | - | - | + | + | - |
| 13 | M | L4 | Schwannoma | + | + | - | - | - | - | + |
| 13 | M | L4L5 | Schwannoma | + | - | - | + | - | - | - |
| 14 | M | T3T7 | Liposarcoma | - | - | - | - | + | + | + |
| 14 | M | C2C3 | HGG | + | + | + | - | - | - | - |
| 14 | M | C2C4 | HGG | - | - | - | - | + | + | - |
| 15 | M | C6 | Cavernous angioma | + | - | - | + | - | - | - |
| 15 | M | T1T2 | Metastatic tumor | + | + | - | - | + | + | + |
| 16 | M | L1 | Schwannoma | + | + | - | + | + | - | - |
| 16 | F | T1T2 | Myxolipoma | - | - | - | - | - | - | - |
| 16 | F | T9T10 | Neuroblastoma | + | + | - | - | - | - | - |
| 17 | F | L1L2 | Arachnoid cyst | + | + | - | - | - | + | - |
| 18 | F | S3 | Osteoblastoma | + | + | - | - | - | - | - |
| 18 | M | L1L2 | MPE | + | + | - | + | - | + | - |
| 18 | M | C1C2, C7 | Neurofibroma | + | + | - | - | + | - | - |
| 19 | F | C6C7 | Medulloblastoma | + | - | - | + | - | + | - |
| 19 | F | T9T11 | LGG | + | + | - | - | + | + | + |
M: male
F: female
MPE: myxopapillary ependymoma
LGG: low-grade glioma
HGG: high-grade glioma
Relationship between tumor location and other parameters
| Extra-
| Intradural
| Intra-
| Pain | Motor
| Sensory
| Urinary
| 0–6
| 7–14
| 15–20
| |
| Cervical
| 3
| 2
| 4
| 5
| 5
| 3
| 1
| 1
| 1
| 2
|
| Thoracic
| 3
| 2
| 4
| 7
| 7
| 7
| 5
| 5
| 4
| 4
|
| Lumbar-Sacral
| 4
| 6
| 0
| 9
| 2
| 2
| 2
| 3
| 4
| 4
|
P < 0.05 by Residual analysis.
Relationship between age and other parameters
| Extradural | Intradural
| Intra-
| Pain | Motor
| Sensory
| Urinary
| |
| 0–6 years
| 1
| 3
| 1
| 1
| 2
| 4
| 3
|
| 7–14 years
| 5
| 5
| 5
| 7
| 5
| 8
| 8
|
| 15–20 years
| 5
| 3
| 3
| 1
| 6
| 5
| 8
|
P < 0.05 by Residual analysis.
Fig. 1Interval between the first symptom and diagnosis for each affected spinal location
*P < 0.05 and **P < 0.01 by the Kruskal-Wallis with post-hoc Bonferroni test.
Fig. 2Interval between the first symptom and diagnosis for each age
Fig. 3Interval between the first symptom and diagnosis for each symptom other than pain
*P < 0.05 by the Mann-Whitney U-test.
Fig. 4Interval between the first symptom and diagnosis for patients with or without pain
Fig. 5Interval between the first symptom and diagnosis for each anatomical tumor location